Genetic Disorders of Vitamin D Synthesis and Action

Genetics of Bone Biology and Skeletal Disease

Volumn , Issue , 2013, Pages 537-552

  Feldman, David ^a   Malloy, Peter J ^b   Miller, Walter L ^c  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b STANFORD UNIVERSITY   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84884001336     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-387829-8.00033-0     Document Type: Chapter

References (122)

1. Feldman D, Malloy PJ, Krishnan AV, Balint E Vitamin D: biology, actions and clinical implications. Osteoporosis 2008, 317-382. Elsevier/Academic Press, Amsterdam. 3rd ed. R. Marcus, D. Feldman, D.A. Nelson, C.J. Rosen (Eds.).
2. Porter FD, Herman GE Malformation syndromes caused by disorders of cholesterol synthesis. J Lipid Res 2011, 52:6-34.
3. Wassif CA, Zhu P, Kratz L, Krakowiak PA, Battaile KP, Weight FF, et al. Biochemical, phenotypic and neurophysiological characterization of a genetic mouse model of RSH/Smith-Lemli-Opitz syndrome. Hum Mol Genet 2001, 10:555-564.
4. Norman AW Sunlight, season, skin pigmentation, vitamin D, and 25-hydroxyvitamin D: integral components of the vitamin D endocrine system. Am J Clin Nutr 1998, 67:1108-1110.
5. Miller WL Minireview: regulation of steroidogenesis by electron transfer. Endocrinology 2005, 146:2544-2550.
6. 3 and glucocorticoids on the growth of rat and mouse osteoblast-like bone cells. Calcif Tissue Int 1983, 35:806-811.
7. 3 25-hydroxylase from rat liver mitochondria. Febs Lett 1990, 262:135-138.
8. 3: gonadotropic regulation of the cognate mRNA in ovaries. DNA Cell Biol 1990, 9:657-667.
9. Cali JJ, Russell DW Characterization of human sterol 27-hydroxylase. A mitochondrial cytochrome P-450 that catalyzes multiple oxidation reaction in bile acid biosynthesis. J Biol Chem 1991, 266:7774-7778.
10. Cali JJ, Hsieh CL, Francke U, Russell DW Mutations in the bile acid biosynthetic enzyme sterol 27-hydroxylase underlie cerebrotendinous xanthomatosis. J Biol Chem 1991, 266:7779-7783.
11. Leitersdorf E, Reshef A, Meiner V, Levitzki R, Schwartz SP, Dann EJ, et al. Frameshift and splice-junction mutations in the sterol 27-hydroxylase gene cause cerebrotendinous xanthomatosis in Jews or Moroccan origin. J Clin Invest 1993, 91:2488-2496.
12. Casella SJ, Reiner BJ, Chen TC, Holick MF, Harrison HE A possible genetic defect in 25-hydroxylation as a cause of rickets. J Pediatr 1994, 124:929-932.
13. Abdullah MA, Salhi HS, Bakry LA, Okamoto E, Abomelha AM, Stevens B, et al. Adolescent rickets in Saudi Arabia: a rich and sunny country. J Pediatr Endocrinol Metab 2002, 15:1017-1025.
14. Lin CJ, Dardis A, Wijesuriya SD, Abdullah MA, Casella SJ, Miller WL Lack of mutations in CYP2D6 and CYP27 in patients with apparent deficiency of vitamin D 25-hydroxylase. Mol Genet Metab 2003, 80:469-472.
15. Cheng JB, Motola DL, Mangelsdorf DJ, Russell DW De-orphanization of cytochrome P450 2R1: a microsomal vitamin D 25-hydroxylase. J Biol Chem 2003, 278:38084-38093.
16. Cheng JB, Levine MA, Bell NH, Mangelsdorf DJ, Russell DW Genetic evidence that the human CYP2R1 enzyme is a key vitamin D 25-hydroxylase. Proc Natl Acad Sci USA 2004, 101:7711-7715.
17. Dong Q, Miller WL Vitamin D 25-hydroxylase deficiency. Mol Genet Metab 2004, 83:197-198.
18. Bieche I, Narjoz C, Asselah T, Vacher S, Marcellin P, Lidereau R, et al. Reverse transcriptase-PCR quantification of mRNA levels from cytochrome (CYP)1, CYP2 and CYP3 families in 22 different human tissues. Pharmacogenet Genomics 2007, 17:731-742.
19. 3. J Mol Biol 2008, 380:95-106.
20. Howard GA, Bottemiller BL, Turner RT, Rader JI, Baylink DJ Parathyroid hormone stimulates bone formation and resorption in organ culture: evidence for a coupling mechanism. Proc Natl Acad Sci U S A 1981, 78:3204-3208.
21. 3 by cultured pulmonary alveolar macrophages in sarcoidosis. J Clin Invest 1983, 72:1856-1860.
22. Bikle DD, Nemanic MK, Gee E, Elias P 1,25-Dihydroxyvitamin D3 production by human keratinocytes. Kinetics and regulation. J Clin Invest 1986, 78:557-566.
23. Hewison M, Adams JS Extra-renal Hydroxylases. Vitamin D 2011, 777-806. Elsevier/Academic Press, Amsterdam. 3rd ed. D. Feldman, J.W. Pike, J.S. Adams (Eds.).
24. Fu GK, Lin D, Zhang MY, Bikle DD, Shackleton CH, Miller WL, et al. Cloning of human 25-hydroxyvitamin D-1α-hydroxylase and mutations causing vitamin D-dependent rickets type 1. Mol Endocrinol 1997, 11:1961-1970.
25. 3 1α-hydroxylase. Biochem Biophys Res Commun 1997, 239:527-533.
26. 3-1α-hydroxylase cDNA. Proc Natl Acad Sci USA 1997, 94:12920-12925.
27. St-Arnaud R, Messerlian S, Moir JM, Omdahl JL, Glorieux FH The 25-hydroxyvitamin D 1α-hydroxylase gene maps to the pseudovitamin D-deficiency rickets (PDDR) disease locus. J Bone Miner Res 1997, 12:1552-1559.
28. 3 1α-hydroxylase and vitamin D synthesis. Science 1997, 277:1827-1830.
29. Fu GK, Portale AA, Miller WL Complete structure of the human gene for the vitamin D 1α-hydroxylase, P450c1alpha. DNA Cell Biol 1997, 16:1499-1507.
30. 3 1α- hydroxylase gene in patients with pseudovitamin D-deficiency rickets. N Engl J Med 1998, 338:653-661.
31. Yoshida T, Monkawa T, Tenenhouse HS, Goodyer P, Shinki T, Suda T, et al. Two novel 1alpha-hydroxylase mutations in French-Canadians with vitamin D dependency rickets type I1. Kidney Int 1998, 54:1437-1443.
32. 3 24-hydroxylase. Febs Lett 1991, 278:195-198.
33. 3 24-hydroxylase cDNA. Proc Natl Acad Sci U S A 1993, 90:4543-4547.
34. 3 24-hydroxylase gene promoter and identification of two vitamin D-responsive elements. Biochim Biophys Acta 1995, 1263:1-9.
35. 3 autoregulation in keratinocytes. J Biol Chem 2002, 277:36987-36990.
36. Annalora AJ, Goodin DB, Hong WX, Zhang Q, Johnson EF, Stout CD Crystal structure of CYP24A1, a mitochondrial cytochrome P450 involved in vitamin D metabolism. J Mol Biol 2010, 396:441-451.
37. Arnaud C, Maijer R, Reade T, Scriver CR, Whelan DT Vitamin D dependency: an inherited postnatal syndrome with secondary hyperparathyroidism. Pediatrics 1970, 46:871-880.
38. Hamilton R, Harrison J, Fraser D, Radde I, Morecki R, Paunier L The small intestine in vitamin D dependent rickets. Pediatrics 1970, 45:364-373.
39. Delvin EE, Glorieux FH, Marie PJ, Pettifor JM Vitamin D dependency: replacement therapy with calcitriol?. J Pediatr 1981, 99:26-34.
40. Balsan S, Garabedian M Rickets, osteomalacia, and osteopetrosis. Current Opin Rheumatol 1991, 3:496-502.
41. Fraser D, Kooh SW, Kind HP, Holick MF, Tanaka Y, DeLuca HF Pathogenesis of hereditary vitamin-D-dependent rickets. An inborn error of vitamin D metabolism involving defective conversion of 25-hydroxyvitamin D to 1α,25-dihydroxyvitamin D. N Engl J Med 1973, 289:817-822.
42. Scriver CR, Reade TM, DeLuca HF, Hamstra AJ Serum 1,25-dihydroxyvitamin D levels in normal subjects and in patients with hereditary rickets or bone disease. N Engl J Med 1978, 299:976-979.
43. Wang JT, Lin CJ, Burridge SM, Fu GK, Labuda M, Portale AA, et al. Genetics of vitamin D 1α-hydroxylase deficiency in 17 families. Am J Hum Genet 1998, 63:1694-1702.
44. Mandla S, Jones G, Tenenhouse HS Normal 24-hydroxylation of vitamin D metabolites in patients with vitamin D-dependency rickets type I. Structural implications for the vitamin D hydroxylases. J Clin Endocrinol Metab 1992, 74:814-820.
45. De Braekeleer M, Larochelle J Population genetics of vitamin D-dependent rickets in northeastern Quebec. Ann Hum Genet 1991, 55:283-290.
46. Labuda M, Morgan K, Glorieux FH Mapping autosomal recessive vitamin D dependency type I to chromosome 12q14 by linkage analysis. Am J Hum Genet 1990, 47:28-36.
47. Labuda M, Labuda D, Korab-Laskowska M, Cole DE, Zietkiewicz E, Weissenbach J, et al. Linkage disequilibrium analysis in young populations: pseudo-vitamin D-deficiency rickets and the founder effect in French Canadians. Am J Hum Genet 1996, 59:633-643.
48. Smith SJ, Rucka AK, Berry JL, Davies M, Mylchreest S, Paterson CR, et al. Novel mutations in the 1α-hydroxylase (P450c1) gene in three families with pseudovitamin D-deficiency rickets resulting in loss of functional enzyme activity in blood-derived macrophages. J Bone Miner Res 1999, 14:730-739.
49. 3 1α-hydroxylase gene product in pseudovitamin D deficiency rickets, including that with mild clinical manifestation. J Clin Endocrinol Metab 1999, 84:4111-4117.
50. Wang X, Zhang MY, Miller WL, Portale AA Novel gene mutations in patients with 1α-hydroxylase deficiency that confer partial enzyme activity in vitro. J Clin Endocrinol Metab 2002, 87:2424-2430.
51. Kim CJ, Kaplan LE, Perwad F, Huang N, Sharma A, Choi Y, et al. Vitamin D 1alpha-hydroxylase gene mutations in patients with 1alpha-hydroxylase deficiency. J Clin Endocrinol Metab 2007, 92:3177-3182.
52. Alzahrani AS, Zou M, Baitei EY, Alshaikh OM, Al-Rijjal RA, Meyer BF, et al. A novel G102E mutation of CYP27B1 in a large family with vitamin D-dependent rickets type 1. J Clin Endocrinol Metab 2010, 95:4176-4183.
53. Edouard T, Alos N, Chabot G, Roughley P, Glorieux FH, Rauch F Short- and long-term outcome of patients with pseudo-vitamin D deficiency rickets treated with calcitriol. J Clin Endocrinol Metab 2011, 96:82-89.
54. Clifton-Bligh RJ, Nguyen TV, Au A, Bullock M, Cameron I, Cumming R, et al. Contribution of a common variant in the promoter of the 1α-hydroxylase gene (CYP27B1) to fracture risk in the elderly. Calcif Tissue Int 2011, 88:109-116.
55. Mast N, Annalora AJ, Lodowski DT, Palczewski K, Stout CD, Pikuleva IA Structural basis for three-step sequential catalysis by the cholesterol side chain cleavage enzyme CYP11A1. J Biol Chem 2011, 286:5607-5613.
56. Strushkevich N, MacKenzie F, Cherkesova T, Grabovec I, Usanov S, Park HW Structural basis for pregnenolone biosynthesis by the mitochondrial monooxygenase system. Proc Natl Acad Sci U S A 2011, 108:10139-10143.
57. Sawada N, Sakaki T, Kitanaka S, Kato S, Inouye K Structure-function analysis of CYP27B1 and CYP27A1. Studies on mutants from patients with vitamin D-dependent rickets type I (VDDR-I) and cerebrotendinous xanthomatosis (CTX). Eur J Biochem 2001, 268:6607-6615.
58. 3 in vitamin D dependency. Pediatr Res 1975, 9:593-599.
59. Mangelsdorf DJ, Thummel C, Beato M, Herrlich P, Schutz G, Umesono K, et al. The nuclear receptor superfamily: the second decade. Cell 1995, 83:835-839.
60. Berg JM Proposed structure for the zinc-binding domains from transcription factor IIIA and related proteins. Proc Natl Acad Sci USA 1988, 85:99-102.
61. Mader S, Kumar V, de Verneuil H, Chambon P Three amino acids of the oestrogen receptor are essential to its ability to distinguish an oestrogen from a glucocorticoid-responsive element. Nature 1989, 338:271-274.
62. Umesono K, Evans RM Determinants of target gene specificity for steroid/thyroid hormone receptors. Cell 1989, 57:1139-1146.
63. Rochel N, Wurtz JM, Mitschler A, Klaholz B, Moras D The crystal structure of the nuclear receptor for vitamin D bound to its natural ligand. Mol Cell 2000, 5:173-179.
64. Blanco JC, Wang IM, Tsai SY, Tsai MJ, O'Malley BW, Jurutka PW, et al. Transcription factor TFIIB and the vitamin D receptor cooperatively activate ligand-dependent transcription. Proc Natl Acad Sci U S A 1995, 92:1535-1539.
65. MacDonald PN, Sherman DR, Dowd DR, Jefcoat SC, DeLisle RK The vitamin D receptor interacts with general transcription factor IIB. J Biol Chem 1995, 270:4748-4752.
66. Malloy PJ, Wang J, Srivastava T, Feldman D Hereditary 1,25-dihydroxyvitamin D-resistant rickets with alopecia resulting from a novel missense mutation in the DNA-binding domain of the vitamin D receptor. Mol Genet Metab 2010, 99:72-79.
67. Malloy PJ, Tiosano D, Feldman D Hereditary 1,25-dihydroxyvitamin D-resistant rickets. Vitamin D 2011, 1197-1232. Elsevier/Academic Press, Amsterdam. 3rd ed. D. Feldman, J.W. Pike, J.S. Adams (Eds.).
68. Malloy PJ, Feldman D Genetic disorders and defects in vitamin D action. Endocrinol Metab Clin North Am 2010, 39:333-346.
69. Malloy PJ, Pike JW, Feldman D The vitamin D receptor and the syndrome of hereditary 1,25-dihydroxyvitamin D-resistant rickets. Endocr Rev 1999, 20:156-188.
70. Malloy PJ, Feldman D The role of vitamin D receptor mutations in the development of alopecia. Mol Cell Endocrinol 2011, 347:90-96.
71. Malloy PJ, Zhou Y, Wang J, Hiort O, Feldman D Hereditary vitamin D-resistant rickets (HVDRR) due to a heterozygous mutation in the vitamin D receptor. J Bone Miner Res 2011, 26:2710-2718.
72. Zhou Y, Wang J, Malloy PJ, Dolezel Z, Feldman D Compound heterozygous mutations in the vitamin D receptor in a patient with hereditary 1,25-dihydroxyvitamin D-resistant rickets with alopecia. J Bone Miner Res 2009, 24:643-651.
73. 3. J Bone Miner Res 2006, 21:886-894.
74. Malloy PJ, Feldman D Molecular defects in the vitamin D receptor associated with hereditary 1,25-dihydroxyvitamin D resistant rickets (HVDRR). Vitamin D: physiology, molecular biology and clinical applications 2010, 691-714. Humana Press. M. Holick (Ed.).
75. 3 resistant rickets in seven related families. J Clin Invest 1990, 86:2071-2079.
76. 3-resistant rickets. J Clin Endocrinol Metab 1997, 82:3892-3894.
77. Hawa NS, Cockerill FJ, Vadher S, Hewison M, Rut AR, Pike JW, et al. Identification of a novel mutation in hereditary vitamin D resistant rickets causing exon skipping. Clin Endocrinol 1996, 45:85-92.
78. Ma NS, Malloy PJ, Pitukcheewanont P, Dreimane D, Geffner ME, Feldman D Hereditary vitamin D resistant rickets: identification of a novel splice site mutation in the vitamin D receptor gene and successful treatment with oral calcium therapy. Bone 2009, 45:743-746.
79. Katavetin P, Wacharasindhu S, Shotelersuk V A girl with a novel splice site mutation in VDR supports the role of a ligand-independent VDR function on hair cycling. Horm Res 2006, 66:273-276.
80. Cockerill FJ, Hawa NS, Yousaf N, Hewison M, O'Riordan JL, Farrow SM Mutations in the vitamin D receptor gene in three kindreds associated with hereditary vitamin D resistant rickets. J Clin Endocrinol Metab 1997, 82:3156-3160.
81. Rut AR, Hewison M, Rowe P, Hughes M, Grant D, O'Riordan JLH A novel mutation in the steroid binding region of the vitamin D receptor (VDR) gene in hereditary vitamin D resistant rickets (HVDRR). Vitamin D: gene regulation, structure-function analysis, and clinical application. Eighth workshop on vitamin D 1991, 94-95. Walter de Gruyter, New York. A.W. Norman, R. Bouillon, M. Thomasset (Eds.).
82. 3: point mutations confer reduced transactivation in response to ligand and impaired interaction with the retinoid X receptor heterodimeric partner. Mol Endocrinol 1996, 10:1617-1631.
83. Malloy PJ, Eccleshall TR, Gross C, Van Maldergem L, Bouillon R, Feldman D Hereditary vitamin D resistant rickets caused by a novel mutation in the vitamin D receptor that results in decreased affinity for hormone and cellular hyporesponsiveness. J Clin Invest 1997, 99:297-304.
84. Malloy PJ, Zhu W, Zhao XY, Pehling GB, Feldman D A novel inborn error in the ligand-binding domain of the vitamin D receptor causes hereditary vitamin D-resistant rickets. Mol Genet Metab 2001, 73:138-148.
85. Macedo LC, Soardi FC, Ananias N, Belangero VM, Rigatto SZ, De-Mello MP, et al. Mutations in the vitamin D receptor gene in four patients with hereditary 1,25-dihydroxyvitamin D-resistant rickets. Arq Bras Endocrinol Metabol 2008, 52:1244-1251.
86. Arita K, Nanda A, Wessagowit V, Akiyama M, Alsaleh QA, McGrath JA A novel mutation in the VDR gene in hereditary vitamin D-resistant rickets. Br J Dermatol 2008, 158:168-171.
87. Malloy PJ, Xu R, Peng L, Clark PA, Feldman D A novel mutation in helix 12 of the vitamin D receptor impairs coactivator interaction and causes hereditary 1,25-dihydroxyvitamin D-resistant rickets without alopecia. Mol Endocrinol 2002, 16:2538-2546.
88. Miller J, Djabali K, Chen T, Liu Y, Ioffreda M, Lyle S, et al. Atrichia caused by mutations in the vitamin D receptor gene is a phenocopy of generalized atrichia caused by mutations in the hairless gene. J Invest Dermatol 2001, 117:612-617.
89. Malloy PJ, Xu R, Cattani A, Reyes L, Feldman D A unique insertion/substitution in helix H1 of the vitamin D receptor ligand binding domain in a patient with hereditary 1,25-dihydroxyvitamin D-resistant rickets. J Bone Miner Res 2004, 19:1018-1024.
90. Malloy PJ, Wang J, Peng L, Nayak S, Sisk JM, Thompson CC, et al. A unique insertion/duplication in the VDR gene that truncates the VDR causing hereditary 1,25-dihydroxyvitamin D-resistant rickets without alopecia. Arch Biochem Biophys 2007, 460:285-292.
91. Hewison M, Rut AR, Kristjansson K, Walker RE, Dillon MJ, Hughes MR, et al. Tissue resistance to 1,25-dihydroxyvitamin D without a mutation of the vitamin D receptor gene. Clin Endocrinol 1993, 39:663-670.
92. Chen H, Hewison M, Hu B, Adams JS Heterogeneous nuclear ribonucleoprotein (hnRNP) binding to hormone response elements: A cause of vitamin D resistance. Proc Natl Acad Sci USA 2003, 100:6109-6114.
93. Li YC, Pirro AE, Amling M, Delling G, Baron R, Bronson R, et al. Targeted ablation of the vitamin D receptor: an animal model of vitamin D-dependent rickets type II with alopecia. Proc Natl Acad Sci U S A 1997, 94:9831-9835.
94. Yoshizawa T, Handa Y, Uematsu Y, Takeda S, Sekine K, Yoshihara Y, et al. Mice lacking the vitamin D receptor exhibit impaired bone formation, uterine hypoplasia and growth retardation after weaning. Nat Genet 1997, 16:391-396.
95. Panda DK, Miao D, Bolivar I, Li J, Huo R, Hendy GN, et al. Inactivation of the 25-hydroxyvitamin D 1alpha-hydroxylase and vitamin D receptor demonstrates independent and interdependent effects of calcium and vitamin D on skeletal and mineral homeostasis. J Biol Chem 2004, 279:16754-16766.
96. Bouillon R, Carmeliet G, Verlinden L, van Etten E, Verstuyf A, Luderer HF, et al. Vitamin D and human health: lessons from vitamin D receptor null mice. Endocr Rev 2008, 29:726-776.
97. LeVine DN, Zhou Y, Ghiloni RJ, Fields EL, Birkenheuer AJ, Gookin JL, et al. Hereditary 1,25-dihydroxyvitamin D-resistant rickets in a Pomeranian dog caused by a novel mutation in the vitamin D receptor gene. J Vet Intern Med 2009, 23:1278-1283.
98. Malloy PJ, Pike JW, Feldman D Hereditary 1,25-dihydroxyvitamin D resistant rickets. Vitamin D 2005, 1207-1238. Elsevier, Amsterdam. 2nd ed. D. Feldman, F. Glorieux, J.W. Pike (Eds.).
99. Van Maldergem L, Bachy A, Feldman D, Bouillon R, Maassen J, Dreyer M, et al. Syndrome of lipoatrophic diabetes, vitamin D resistant rickets, and persistent müllerian ducts in a Turkish boy born to consanguineous parents. Am J Med Genet 1996, 64:506-513.
100. 3 in a patient without alopecia. Eur J Pediatr 1986, 145:389-395.
101. Balsan S, Garabedian M, Liberman UA, Eil C, Bourdeau A, Guillozo H, et al. Rickets and alopecia with resistance to 1,25-dihydroxyvitamin D: two different clinical courses with two different cellular defects. J Clin Endocrinol Metab 1983, 57:803-811.
102. Balsan S, Garabedian M, Larchet M, Gorski AM, Cournot G, Tau C, et al. Long-term nocturnal calcium infusions can cure rickets and promote normal mineralization in hereditary resistance to 1,25-dihydroxyvitamin D. J Clin Invest 1986, 77:1661-1667.
103. Weisman Y, Bab I, Gazit D, Spirer Z, Jaffe M, Hochberg Z Long-term intracaval calcium infusion therapy in end-organ resistance to 1,25-dihydroxyvitamin D. Am J Med 1987, 83:984-990.
104. Bliziotes M, Yergey AL, Nanes MS, Muenzer J, Begley MG, Viera NE, et al. Absent intestinal response to calciferols in hereditary resistance to 1,25-dihydroxyvitamin D: documentation and effective therapy with high dose intravenous calcium infusions. J Clin Endocrinol Metab 1988, 66:294-300.
105. Hochberg Z, Tiosano D, Even L Calcium therapy for calcitriol-resistant rickets. J Pediatr 1992, 121:803-808.
106. Forghani N, Lum C, Krishnan S, Wang J, Wilson DM, Blackett PR, et al. Two new unrelated cases of hereditary 1,25- dihydroxyvitamin D-resistant rickets with alopecia resulting from the same novel nonsense mutation in the vitamin D receptor gene. J Pediatr Endocrinol Metab 2010, 23:843-850.
107. Sakati N, Woodhouse NJY, Niles N, Harfi H, de Grange DA, Marx S Hereditary resistance to 1,25-dihydroxyvitamin D: clinical and radiological improvement during high-dose oral calcium therapy. Hormone Res 1986, 24:280-287.
108. Hochberg Z, Benderli A, Levy J, Vardi P, Weisman Y, Chen T, et al. 1,25-Dihydroxyvitamin D resistance, rickets, and alopecia. Am J Med 1984, 77:805-811.
109. Hirst MA, Hochman HI, Feldman D Vitamin D resistance and alopecia: a kindred with normal 1,25-dihydroxyvitamin D binding, but decreased receptor affinity for deoxyribonucleic acid. J Clin Endocrinol Metab 1985, 60:490-495.
110. Chen TL, Hirst MA, Cone CM, Hochberg Z, Tietze HU, Feldman D 1,25-dihydroxyvitamin D resistance, rickets, and alopecia: analysis of receptors and bioresponse in cultured fibroblasts from patients and parents. J Clin Endocrinol Metab 1984, 59:383-388.
111. Goltzman D, Miao D, Panda DK, Hendy GN Effects of calcium and the Vitamin D system on skeletal and calcium homeostasis: lessons from genetic models. J Steroid Biochem Mol Biol 2004, 89-90:485-489.
112. Chen CH, Sakai Y, Demay MB Targeting expression of the human vitamin D receptor to the keratinocytes of vitamin D receptor null mice prevents alopecia. Endocrinology 2001, 142:5386-5389.
113. Li M, Chiba H, Warot X, Messaddeq N, Gerard C, Chambon P, et al. RXRα ablation in skin keratinocytes results in alopecia and epidermal alterations. Development 2001, 128:675-688.
114. Hsieh JC, Sisk JM, Jurutka PW, Haussler CA, Slater SA, Haussler MR, et al. Physical and functional interaction between the vitamin D receptor and hairless corepressor, two proteins required for hair cycling. J Biol Chem 2003, 278:38665-38674.
115. Malloy PJ, Feldman D Hereditary 1,25-Dihydroxyvitamin D-resistant rickets. Endocr Dev 2003, 6:175-199.
116. Skorija K, Cox M, Sisk JM, Dowd DR, MacDonald PN, Thompson CC, et al. Ligand-independent actions of the vitamin D receptor maintain hair follicle homeostasis. Mol Endocrinol 2005, 19:855-862.
117. Ahmad W, Faiyaz ul Haque M, Brancolini V, Tsou HC, ul Haque S, Lam H, et al. Alopecia universalis associated with a mutation in the human hairless gene. Science 1998, 279:720-724.
118. Wang J, Malloy PJ, Feldman D Interactions of the vitamin D receptor with the corepressor hairless: analysis of hairless mutants in atrichia with papular lesions. J Biol Chem 2007, 282:25231-25239.
119. Xie Z, Chang S, Oda Y, Bikle DD Hairless suppresses vitamin D receptor transactivation in human keratinocytes. Endocrinology 2006, 147:314-323.
120. Beaudoin GM, Sisk JM, Coulombe PA, Thompson CC Hairless triggers reactivation of hair growth by promoting Wnt signaling. Proc Natl Acad Sci U S A 2005, 102:14653-14658.
121. Thompson CC, Sisk JM, Beaudoin GM Hairless and Wnt signaling: allies in epithelial stem cell differentiation. Cell Cycle 2006, 5:1913-1917.
122. Luderer HF, Demay MB The vitamin D receptor, the skin and stem cells. J Steroid Biochem Mol Biol 2010, 121:314-316.